Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,880.00p
   
  • Change Today:
    -11.00p
  • 52 Week High: 2,205.00p
  • 52 Week Low: 1,722.00p
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 6,229
  • Market Cap: £4,171.44m
  • RiskGrade: 125

Tuesday broker round-up

By Conor Coyle

Date: Tuesday 23 May 2017

LONDON (ShareCast) - (ShareCast News) - EasyJet: RBC upgrades to Sector Perform with a target price of 1325p.
B&M: HSBC reiterates Buy with a target price of 400p.

Petrofac: Deutsche Bank reiterates Sell with a target price of 600p.

Lonmin: Citi reiterates Sell/High risk with a target price of 95p.

Hikma Pharmaceuticals: JPMorgan reiterates Neutral with a target price of 1500p.

Associated British Foods: Jefferies reiterates Buy with a target price of 3500p.

Randgold Resources: Goldman Sachs reiterates Neutral with a target price of 7700p.

Legal and General: Morgan Stanley reiterates Equal Weight with a target price of 250p.

Safestay: Canaccord reiterates Buy with a target price of 65p.

Wood Group: Deutsche Bank reiterates Buy with a target price of 850p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,880.00p
Change Today -11.00p
% Change -0.58 %
52 Week High 2,205.00p
52 Week Low 1,722.00p
Volume 6,229
Shares Issued 221.89m
Market Cap £4,171.44m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.07% below the market average48.07% below the market average48.07% below the market average48.07% below the market average48.07% below the market average
1.96% above the sector average1.96% above the sector average1.96% above the sector average1.96% above the sector average1.96% above the sector average
Price Trend
44.88% above the market average44.88% above the market average44.88% above the market average44.88% above the market average44.88% above the market average
69.81% above the sector average69.81% above the sector average69.81% above the sector average69.81% above the sector average69.81% above the sector average
Income
11.05% above the market average11.05% above the market average11.05% above the market average11.05% above the market average11.05% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
31.5% below the market average31.5% below the market average31.5% below the market average31.5% below the market average31.5% below the market average
39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 1
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 21-Mar-24 10-Aug-23
Paid 03-May-24 15-Sep-23
Amount 47.00¢ 25.00¢

Trades for 01-Jul-2024

Time Volume / Share Price
08:58 103 @ 1,880.00p
08:58 2 @ 1,880.00p
08:58 45 @ 1,880.00p
08:55 25 @ 1,882.00p
08:55 24 @ 1,881.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page